SCHEMBL6805065

SCHEMBL6805065

O=C1CC[CH]N1Cc1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 1/20 0.48
HTT P42858 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
DRD4 P21917 3/20 0.40
DRD3 P35462 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7820085 0.75 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL6805692 0.70 TSHR (0.49) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL8447095 0.70 L3MBTL1 (0.54) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL8114202 0.69 HTT (0.64) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL6944202 0.69 HTT (0.64) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL14628034 0.67 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL3950619 0.67 L3MBTL1 (0.50) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL28452624 0.66 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL10722541 0.66 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AHSD17B10MAPT
SCHEMBL10928551 0.66 MAPT (0.46) ALDH1A1MEN1KMT2AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040132809-A1 Cell adhesion inhibitors BIOGEN, INC. 2004-07-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132809-A1 Cell adhesion inhibitors VCAM1, ICAM1, EPCAM ALDH1A1 631/4885MEN1 3126/4885KMT2A 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.